Aclarion, Inc.
ACONW- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001635077
In the last 90 days, Aclarion, Inc. insiders filed 6 open-market purchases and 0 sales; 4 institutions reported holding it in 13F filings for Q2 2026, worth $3.08K in total; no superinvestor holds it.
Other share classesACON
Key figures
- Insider buysLast 90 days, $125.7K in total
- 6
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +1 vs. previous quarter
- 4
- 13F valueReported value at the end of Q2 2026
- $3.08K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding ACONW, Q2 2026
No superinvestor reported holding ACONW at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Aclarion, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 (view filing)8:30 AM ET | Aug 17 | 2 days | Sequira Amanda MaeDirector | PPurchase | +5.86K | $2.73 | +$16.0K | +29.3%25.9K after | |
| Aug 18, 2026 (view filing)8:30 AM ET | Aug 14 | 4 days | Gould Gregory ACFO | PPurchase | +10.0K | $2.45 | +$24.5K | +20.0%60.0K after | |
| Aug 17, 2026 (view filing)8:30 AM ET | Aug 13 | 4 days | Bond RyanDirector | PPurchase | +21.1K | $2.37 | +$50.1K | +38.4%76.1K after | |
| Aug 17, 2026 (view filing)8:30 AM ET | Aug 13 | 4 days | Wesemann WilliamDirector | PPurchase | +2.15K | $2.34 | +$5.03K | +10.0%23.7K after | |
| Aug 17, 2026 (view filing)8:30 AM ET | Aug 13 | 4 days | Neal David KDirector | PPurchase | +7.50K | $2.40 | +$18.0K | +33.3%30.0K after | |
| Aug 17, 2026 (view filing)8:30 AM ET | Aug 13 | 4 days | Ness BrentChief Executive Officer | PPurchase | +5.23K | $2.31 | +$12.1K | +4.9%111.5K after | |
| May 12, 2026 (view filing) | May 12 | Same day | Breidbart ScottDirector | PPurchase | +5.66K | $3.18 | +$18.0K | New position5.66K after | |
| May 12, 2026 (view filing) | May 11 | 1 day | Neal David KDirector | PPurchase | +2.50K | $3.10 | +$7.75K | +125,000.0%2.50K after | |
| May 11, 2026 (view filing) | May 11 | Same day | Ness BrentChief Executive Officer | PPurchase | +6.29K | $3.18 | +$20.0K | +57,172.7%6.30K after | |
| May 8, 2026 (view filing) | May 6 | 2 days | Wesemann WilliamDirector | PPurchase | +1.56K | $3.30 | +$5.15K | +156,200.0%1.56K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Aclarion, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Captrust Financial Advisors | 78,400 | $1.69K | 0.00% | 00.0% | Unchanged |
| Clear Street Group Inc. | 47,023 | $1.01K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 12,099 | $260 | 0.00% | +12,099 | New |
| UBS Group AG | 5,786 | $122 | 0.00% | +5,786 | New |